# Multi Neuro-functional Biomarkers for Monitoring the Effects of Treatments in ADHD Children

> **NCT04272021** · PHASE4 · UNKNOWN · sponsor: **IRCCS Eugenio Medea** · enrollment: 20 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Methylphenidate

## Key facts

- **NCT ID:** NCT04272021
- **Lead sponsor:** IRCCS Eugenio Medea
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-13
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04272021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04272021, "Multi Neuro-functional Biomarkers for Monitoring the Effects of Treatments in ADHD Children". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04272021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*